NeuroDerm (NDRM) Commences Enrollment in ND0612L Phase 3 as Parkinson's Disease Treatment
Go back to NeuroDerm (NDRM) Commences Enrollment in ND0612L Phase 3 as Parkinson's Disease Treatment(NASDAQ: NDRM) | Delayed: 38.85 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $38.85 | 52 Week High | $20.52 | |||
Open | $0.01 | 52 Week Low | $11.76 | |||
Day High | $38.85 | P/E | N/A | |||
Day Low | $38.85 | EPS | $0.00 | |||
Volume | 6,699 |